Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch(Universitat de Barcelona), Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Jose T. Ortiz‐Pérez(Hospital Quirón Teknon), Rosario J. Perea(Hospital Clínic de Barcelona), Mariano Monzó(Hospital de León), Teresa M. de Caralt(European Molecular Biology Laboratory), Manuel Morales‐Ruiz(Universitat de Barcelona), Ariadna Domènech(Hospital Clínic de Barcelona), Montserrat Rovira(Humanitas University), Marta Sitges(Hospital Clínic de Barcelona)
Cited by 631
Related Papers
The ‘Digital Twin’ to enable the vision of precision cardiology
|European Heart Journal|2020|811
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
|Radiographics|2010|490
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
|JAMA Neurology|2017|274
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
|Hepatology|2007|261
Therapy-Related Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2003|215